ADAMTS13 and hemolytic-uremic syndrome: The difference between TTP and other TMAs including hemolytic uremic syndrome (HUS), atypical HUS, complement-mediated TMA, and drug-induced TMA is basically the deficiency of ADAMTS13 enzyme activity [2,3].